Skip to main content

MS clinical trial to focus on people who can’t walk

The first multiple sclerosis (MS) clinical trial to focus only on people who can’t walk is to start recruiting. The ChariotMS trial, led by researchers at Queen Mary University of London, will test whether cladribine tablets (Mavenclad®), already licensed for highly active relapsing MS, can slow the rate of upper limb disability progression in people with advanced MS.

Published on:
Back to top